ENTRADA THERAPEUTICS INC
TRDA·29384C108·US·Common Stock·Healthcare - Biotechnology-Activist
TRDA (ENTRADA THERAPEUTICS INC) is held by 80 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($64M), BlackRock, Inc. ($29.8M), VANGUARD CAPITAL MANAGEMENT LLC ($15.9M). Net institutional sentiment: Mixed.
80
Holders
Avg rating(16 Elite)
$211.3M
Total Value
55% (86)
Fund Consensus
42 buying - 34 selling
Who's Trading
InsiderSNSethuraman NatarajanSell $399KMay 4, 2026
InsiderDJDowden Nathan JExercise 15K shMay 4, 2026
InsiderDJDowden Nathan JSell $230KMay 4, 2026
InsiderWJWENTWORTH KORY JAMESSell $32KApr 1, 2026
InsiderDJDowden Nathan JSell $155KMar 10, 2026
InsiderWJWENTWORTH KORY JAMESSell $148KMar 10, 2026
InsiderDJDowden Nathan JSell $41KMar 9, 2026
InsiderWJWENTWORTH KORY JAMESSell $66KMar 9, 2026
ActivistTCTCG Crossover GP I, LLC5.0%Nov 25, 2025
Activist5V5AM Ventures V, L.P.7.8%Nov 18, 2025
13F: Insider & Congress:
Showing 1-20 of 86
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer